ClinicalTrials.gg
RecruitingNCT07864103Updated Nov 10, 2026

Efficacy of Electric Fans in Children During Heat Waves

An interventional study of Simulated exposure to indoor overheating without fans and Simulated exposure to indoor overheating with fans in Heat Stress, Physiological Stress and Child Development, sponsored by University of Ottawa. Recruiting at 1 site in Canada. Open to participants aged 9 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by University of Ottawa · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 7, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
9 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Heat Stress Disorders by University of Ottawa — 10 open to participants now, 13 under way, none of them phase 3. Heat Stress Disorders · University of Ottawa.

Planned enrollment
Largest of 30
60 · median 16
Started
2026
with 6 others
No phase
30 of 30
10 open now
Primary completion
2027-04
later than 6 of 12 live
Registered
30th of 30
by date

Among the 30 studies in Heat Stress Disorders by University of Ottawa, this one has the largest planned enrollment, is one of 7 that started in 2026, is one of 30 with no phase, reaches primary completion later than 6 of the 12 other live ones, and was the 30th registered.

Heat Stress Disorders

118 studies on the registry are indexed under Heat Stress Disorders; 42 are open to participants now.

Browse Heat Stress Disorders studies →

Open to participants now

10 of the 30 studies in Heat Stress Disorders by University of Ottawa are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 30 Heat Stress Disorders studies recruiting now, 8 (27%) set no upper age limit and 18 (60%) stop at 75 or younger; 6 take children under 18; 22 take healthy volunteers.

This study: 9 Years to 25 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Heat Stress Disorders by University of Ottawa, or all of them as a file.
02

Study summary

Extreme heat exposure is an escalating global public health concern, with climate change driving increases in the frequency, duration, and intensity of heat events. Projections indicate substantial increases in heat-related morbidity and mortality in the coming decades, including among children and youth, who are increasingly recognized as a physiologically vulnerable population. The purpose of this project is to evaluate the effectiveness of commonly used heat-mitigation strategies, specifically midday access daylong electric fan use, in reducing physiological strain and maintaining cognitive function, perceptual comfort, and psychological well-being in children and youth exposed to prolonged indoor heat. The study also aims to determine whether these strategies provide comparable protection in children and youth relative to young adults. Participants will complete four sessions under the same environmental conditions (31°C and 36°C), with each temperature completed twice: once with continuous electric fan use and once without fan use. The four sessions therefore consist of: (1) 31°C without fan use; (2) 31°C with fan use; (3) 36°C without fan use; and (4) 36°C with fan use.

03

Conditions studied

  • Heat Stress
  • Physiological Stress
  • Child Development

Browse trials for

04

Who can participate

Ages eligible
9 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be healthy males or females within the specified age ranges (9-12 years, 13-16 years, or 20-25 years).
  • All participants must be habitually active, defined as participation in regular physical activity at least three times per week for a minimum of 20 minutes per session over the previous six months.
  • Participants must be able to understand and communicate in English or French.
  • For participants under 18 years of age, written parental or guardian consent and participant assent will be required prior to participation.

Exclusion criteria

Exclusion Criteria:

  • Individuals will be excluded from participation if they have any acute illness at the time of testing (e.g., cold, flu, or infection), or a history of chronic medical conditions that may affect thermoregulation, cardiovascular function, or exercise capacity, including but not limited to cardiovascular, metabolic, respiratory, or neurological disorders. Individuals taking medications known to influence thermoregulation, hydration status, or cardiovascular responses will also be excluded.
  • Participants with a history of heat-related illness (e.g., heat exhaustion or heat stroke) will not be eligible.
  • Individuals with digestive abnormalities or gastrointestinal conditions that may contraindicate ingestion of a telemetry pill will also be excluded.
  • Any individual who, in the opinion of the investigators, may be at increased risk or unable to safely complete the study procedures will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Warm indoor environment of 31°C without fans

    Participants exposed daylong (6 hours) to an indoor temperature maintained at 31°C and 45% relative humidity without fan exposure.

    Other: Simulated exposure to indoor overheating without fans

  • Experimental
    Warm indoor environment of 31°C with fans

    Participants exposed daylong (6 hours) to an indoor temperature maintained at 31°C and 45% relative humidity with fan exposure.

    Other: Simulated exposure to indoor overheating with fans

  • Experimental
    Hot indoor environment of 36°C without fans

    Participants exposed daylong (6 hours) to an indoor temperature maintained at 36°C and 45% relative humidity with fan exposure.

    Other: Simulated exposure to indoor overheating without fans

  • Experimental
    Hot indoor environment of 36°C with fans

    Participants exposed daylong (6 hours) to an indoor temperature maintained at 36°C and 45% relative humidity with fan exposure.

    Other: Simulated exposure to indoor overheating with fans

Interventions

  • OtherSimulated exposure to indoor overheating without fans

    Children and young adults exposed to a 6-hour simulated heat exposure without fans.

  • OtherSimulated exposure to indoor overheating with fans

    Children and young adults exposed to a 6-hour simulated heat exposure without fans.

06

What researchers measure

Primary outcomes

  1. Core temperature (Peak) during daylong exposure to indoor overheating

    Peak core (indexed by visceral temperature) temperature (15 min average) during exposure. Visceral temperature is measured continuously throughout the 6 hour exposure to the simulated indoor overheating.

    Time frame: End of 6 hour daylong exposure

Secondary outcomes

  1. Profiles of Mood States (POMS) during daylong exposure to indoor overheating

    Potential changes in mood (7 subscales of mood: tension, anger, depression, fatigue, confusion, vigor and esteem related affect). The POMS-40 is a validated, self-administered questionnaire that examines seven distinct aspects of mood state across two positive subscales (Esteem-Related Affect, and Vigor) and five negative subscales (Fatigue, Tension, Confusion, Anger, and Depression), which are described across 40 distinct adjectives. For each individual item, participants are asked to describe "how you feel right now" by responding using a 5-point Likert scale (0 = "Not at all", 1 = "A little", 2 = "Moderately", 3 = "Quite a lot", or 4 = "Extremely"). The values of items associated with a specific subscale (e.g., Fatigue) are summed to calculate its score.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  2. Environmental Symptoms Questionnaire (ESQ) during daylong exposure to indoor overheating

    Self-reported environmental reactions and medical symptomatology associated with prolonged heat exposure. The ESQ-IV is a validated 68-item, self-administered questionnaire that has been used successfully in identifying symptomatology during exposure to a wide variety of environmental conditions, including heat exposure. Participants are asked to assess and described "how you have been feeling today" by responding to each item using a 6-point Likert scale (0 = "Not at all", 1 = "Slight", 2 = "Somewhat", 3 = "Moderate", 4 = "Quite a bit", or 5 = "Extreme"). Total Symptom Score is calculated from this data by taking the sum of the intensity ratings from all 68 individual items using reverse scores for the three positive items from the list ("I Felt Good", "I Felt Alert", and "I Felt Wide Awake").

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  3. Perceived exertion scale during daylong exposure to indoor temperature limit

    Perceived exertional assessed via an ordinal scale ("How hard are you working?") ranging from "no exertional at all" to "maximal exertion"

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  4. Activity levels (total steps taken) during daylong exposure to indoor overheating

    Activity levels, quantified by number of steps taken per hour and totaled for each 6 hour exposure, assessed via a wearable accelerometer worn on the wrist and hip.

    Time frame: End of 6 hour daylong exposure

  5. Feel good scale during daylong exposure to indoor overheating

    Feel good scale assessed via an ordinal scale (How good do you feel?) ranging from "very good" to "very bad" (midpoint: neutral)

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  6. Thirst sensation scale during daylong exposure to indoor overheating

    Thirst sensation assessed via an ordinal scale ranging from very, very thirsty to not thirsty at all.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  7. Thermal comfort scale during daylong exposure to indoor overheating

    Thermal comfort assessed via an ordinal scale ("How comfortable does your body temperature feel?") ranging from "very uncomfortable" to "comfortable".

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  8. Thermal sensation 2 scale during daylong exposure to indoor overheating

    Thermal sensation assessed via an ordinal scale ("How do you feel?") ranging from "hot" to "cold" (midpoint: neutral)

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  9. Thermal sensation scale during daylong exposure to indoor overheating

    Thermal sensation assessed via an ordinal scale (How hot do you feel?) ranging from "extremely hot" to "neutral".

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  10. Fluid loss during daylong exposure to indoor overheating

    Fluid loss calculated as the change in body mass during each exposure presented as a percentage of baseline body mass (corrected for food consumption).

    Time frame: At end of 6 hour daylong exposure

  11. Fluid consumption during daylong exposure to indoor overheating

    Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).

    Time frame: At end of 6 hour daylong exposure

  12. Hydration status during daylong exposure to indoor overheating

    Hydration status measured via assessing the urine specific gravity of a urine sample.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  13. BTrackS Balance Assessment during daylong exposure to indoor overheating (postural stability)

    To assess postural stability, participants will be asked to stand on a BTracks force plate with their feet spread out to shoulder width, hand on their hips and eyes closed. The assessment will comprise of four trials (one practice trial) lasting 20 seconds in length and 20 seconds between trials. Center of pressure (COP) vector data along vertical (y) and horizontal (x) axes will be summed for the total path excursion length (cm) during each trial

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  14. Executive function during daylong exposure to indoor overheating (cognitive function).

    Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of executive function. Participants will complete the Cued Stroop test, in which they are presented a sequence of congruent, neutral and incongruent color-word tasks.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  15. CDC 4-Stage Balance Test during daylong exposure to indoor overheating (postural stability).

    To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc).

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  16. Memory recall during daylong exposure to indoor overheating (cognitive function).

    Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  17. Impulse control during daylong exposure to indoor overheating (cognitive function).

    Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  18. Reaction time during daylong exposure to indoor overheating (cognitive function).

    Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of reaction time. Participants will be asked to initiate a movement of the device in response to a visual cue.

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  19. Diastolic blood pressure during daylong exposure to indoor overheating.

    Diastolic blood pressure measured in triplicate via automated oscillometry (\~60 seconds between measures).

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  20. Systolic blood pressure during daylong exposure to indoor overheating

    Systolic blood pressure measured in triplicate via automated oscillometry (\~60 seconds between measures).

    Time frame: At the start (hour 0) and end of 6 hour daylong exposure

  21. Heart rate end of daylong exposure to indoor overheating

    Heart rate measured at hour 6 of exposure to indoor overheating (15-min average).

    Time frame: End of 6 hour daylong exposure

  22. Heart rate (AUC) during daylong exposure to indoor overheating

    Areas under the curve (AUC) of heart rate during the 6 hour exposure to the simulate indoor overheating.

    Time frame: End of 6 hour daylong exposure

  23. Heat rate (Peak) during daylong exposure to indoor overheating

    Peak heart rate (15 min average) during exposure. Heart rate is measured continuously throughout the 6 hour exposure to the simulated indoor overheating.

    Time frame: End of 6 hour daylong exposure

  24. Mean skin temperature end of daylong exposure to indoor overheating

    Mean skin temperature measured over 7 body regions at hour 6 of exposure to indoor overheating (15-min average).

    Time frame: End of 6 hour daylong exposure

  25. Mean skin temperature (AUC) during daylong exposure to indoor overheating

    Areas under the curve (AUC) of mean skin temperature as calculated over 7 body regions during the 6 hour exposure to the simulate indoor overheating.

    Time frame: End of 6 hour daylong exposure

  26. Mean skin temperature (Peak) during daylong exposure to indoor overheating

    Peak mean skin temperature (15 min average) during exposure. Mean skin temperature as calculated from skin temperature measured across 7 body regions is measured continuously throughout the 6 hour exposure to the simulated indoor overheating.

    Time frame: End of 6 hour daylong exposure

  27. Core temperature end of daylong exposure to indoor overheating

    Visceral temperature measured at hour 6 of exposure to indoor overheating (15-min average).

    Time frame: End of 6 hour daylong exposure

  28. Core temperature (AUC) during daylong exposure to indoor overheating

    Areas under the curve (AUC) of visceral temperature during the 6 hour exposure to the simulate indoor overheating.

    Time frame: End of 6 hour daylong exposure

07

Study locations

1 of 1 sites recruiting
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Apr 2027, 6 months after the start.

Of 77 non-industry interventional studies with no phase under Heat Stress Disorders, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 6 months is below that.

Counting every sponsor, half of 77 studies reached it within 14 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 7, 2026
StartActual
Oct 2, 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 2 updates
  1. Nov 10, 2026
    Minor edits only
    + 2 other changes: verification date and date precision
  2. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07864103
Responsible party
Glen P. Kenny (Full Professor, University Research Chair, University of Ottawa) — Principal investigator
First posted
Oct 7, 2026
Start date
Oct 2, 2026
Primary completion
Apr 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Glen P Kenny
Contact
gkenny@uottawa.ca
613-562-5800 ext. 4282

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion